<p>Connect Biopharma Holdings Ltd. announced that Kan Chen, Ph.D., a partner at Qiming Venture Partners, has resigned from its Board of Directors and the Nominating and Corporate Governance Committee, effective immediately. The resignation follows the company’s recent shift to a more U.S.-centric strategy. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Connect Biopharma Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001835268-25-000061), on December 23, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

CNTB

<p>Connect Biopharma Holdings Ltd. announced the resignation of Kan Chen, Ph.D., from its Board of Directors and the Nominating and Corporate Governance Committee. This decision aligns with the company's recent shift to a more U.S.-centric strategy. The announcement was made via EDGAR by the U.S. Securities and Exchange Commission.</p>

Connect Biopharma Board Member Kan Chen Resigns